NEO
NeoGenomics Inc.
Company Overview
| Mkt Cap | $1.10B | Price | $10.18 |
| Volume | 1.91M | Change | +4.04% |
| P/E Ratio | -14.0 | Open | $9.60 |
| Revenue | $660.6M | Prev Close | $9.78 |
| Net Income | $-78.7M | 52W Range | $4.72 - $19.11 |
| Div Yield | N/A | Target | $12.56 |
| Overall | 56 | Value | 60 |
| Quality | 47 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyNeoGenomics Inc. (NEO) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $9.90 with a market capitalization of $1.10 billion. The stock is in the lower portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows NEO with a volume of 1.87 million shares. The stock opened up 0.31% from yesterday's close of $9.77. Current analyst estimates project earnings of $-0.25 per share for this year, with next year targeting $-0.14.
NEO demonstrates positive technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including BRLI, RDNT, DGX, LH, PMD.
Key investment considerations for NEO include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 26.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 12:54 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NEO | $10.18 | +4.0% | 1.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |